We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

This study has been terminated.
(This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01883011
First Posted: June 21, 2013
Last Update Posted: August 30, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
UCB Pharma ( UCB S.A. - Pharma Sector )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2001
  Primary Completion Date: July 2001 (Final data collection date for primary outcome measure)